MPharm Pharmacy / Course details

A-level chemistry will be helpful.

This module will provide essential knowledge for understanding the basic processes involved in the development of medicines. The course will follow a path from selecting a drug target through to manufacture of safe and effective formulations.

Semester 1

Consolidated examination: (25% contribution to the unit mark).

Theoretical practical exam: (10% contribution to the unit mark).

Practical lab exam (from Sem 1) (10% contribution to the unit mark).

Summative assessment: (5% contribution to the unit mark)

Semester 2

Consolidated examination: (25% contribution to the unit mark).

Practical report (5%) case study exam (15%): (20% contribution to the unit mark).

Summative assessment: (5% contribution to the unit mark)

 Notes

The consolidated exams will contain questions from all three units (The Medicine, The Public and The Patient) contributing equally. Students must achieve a minimum of 40% over both semesters in the Medicine sections of the consolidated exam to pass.

 Three component marks will be reported to the Examination Board as below.  In order to pass this module you will need at least 40% in each of the following components:

Component 1: Semester 1 and semester 2 consolidated exams contribute 50% to the overall mark for the unit.  Exam marks refers to marks received for “The Medicine” part of the consolidated exam. Students must achieve a minimum of 40% over both semesters in the Medicine sections of the consolidated exam.

Component 2: Marks for practical exam, practical course work and case study exam will be combined from both semesters to generate a single component mark which contributes 50% of the overall mark for this unit.

Component                                 Percentage     Equivalent credits
Consolidated exams                   50%                 10
Coursework                                50%                  10

Online, tutorials, and during practical + case study sessions.

Pharmaceutical Analysis, D.G. Watson, Churchill Livingstone (see link above). Pages 1-25 ,90-114, 115-135, 165- 194, 204-248, 265-298, 301-395, 358-375, 398-414.

Aulton’s Pharmaceutics: The design and manufacture of medicines. 3rd Edition. Ed. Aulton, Churchill Livingstone (2007). Pages 4-14, 99-107 , 351-254, 266-303, 358-359, 399-403, 483-499, 565-597, 637-638, 650-665

Cal Packages: http://www.collegeofpharmacy.com/

‘Clarkes analysis of Drugs and Poisons,’ London Pharmaceutical Press. Electronic Version can be found through ‘Medicines’ Complete’ which is accessed through the John Rylands e-database collection. Methodology & Analytical Techniques section Chapters 11, 21, 32,33,36,37,38,39,40

British Pharmacopoeia

https://www.pharmacopoeia.com/bp-2015?date=2015-01-01

https://www.medicinescomplete.com/mc/

Organic Spectroscopic Analysis," R.J. Anderson, D.J. Bendell and P.W. Groundwater, Cambridge, Royal Society of Chemistry, 2004.

Spectroscopic Methods in Organic Chemistry. D.H. Williams and I. Flemming, London, McGraw-Hill, 1995, 5th edition.

Essentials of Pharmaceutical Chemistry” (2nd ed) D. Cairns, Pharmaceutical Press, London,

2003. E-book is currently available (see link below):

http://lib.myilibrary.com/Browse/Open.asp?ID=179402

Physio-chemical Principles of Pharmacy, Florence & Attwood, 3rd Ed. Macmillian, 1997. The 4th ed. (2005) is available as E book:

http://lib.myilibrary.com/Browse/Open.asp?ID=113012

Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2007, ‘The Orange Guide.’ Author MHRA, Published HMSO.